Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Doxycycline for Injection USP.
30-09-2017

Zydus Cadila gets final nod from USFDA for anti-bacteria drug

Zydus Cadila has received final approval from the US food and drug administration (USFDA) to market doxycycline tablets, used for treatment of different types of bacterial infections
29-09-2017
Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Doxycycline Tablets USP.
29-09-2017
Bigul

Zydus Cadila gets USFDA nod for anti-inflammatory drug

Zydus Cadila has received final approval from the US health regulator to market indomethacin extended release capsules used in treating painful and inflammatory conditions such as arthritis. The...
27-09-2017
Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Indomethacin Extended-Release Capsules USP
27-09-2017
Bigul

Zydus Cadila gets USFDA nod to sell hypertension drug

The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applications
23-09-2017
Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Amlodipine and Olmesartan Medoxomil Tablets
23-09-2017
Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Itraconazole Capsules 100 mg.
21-09-2017
Bigul

Zydus Cadila gets final FDA nod for skin disorder, hypertension drugs

While Desoximetasone ointment is used for treatment of symptoms of a skin disease, Labetalol hydrochloride tablets are used for the treatment of high blood pressure
20-09-2017
Bigul

Press Release / Media Release

Zydus receives final approval from the USFDA for Desoximetasone Ointment and Labetalol Hydrochloride Tablets
20-09-2017
Next Page
Close

Let's Open Free Demat Account